Warp Sciences
US chemistry contract research organization that combines medicinal chemists, AI and lab robotics to make research compounds for biotech and pharma drug discovery teams.
Warp Sciences has raised $215M across 1 disclosed round since Oct 22, 2026; the latest round, Series A, was announced on Oct 22, 2026. Data as of Oct 23, 2026.
Headquartered in United States.
Latest from MEKAWIRE
No rival relationships reviewed yet
Rivals are only shown with a stated reason; nothing here is inferred without evidence.